<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0003354'>Astrogliosis</z:mp> occurs after <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>, and excessive <z:mp ids='MP_0003354'>astrogliosis</z:mp> can devastate the neuronal recovery </plain></SENT>
<SENT sid="1" pm="."><plain>Previous reports show that galectin-1 (<z:chebi fb="125" ids="28260">Gal</z:chebi>-1) regulates proliferation of several cell types and plays an important role after <z:mp ids='MP_0008912'>nervous</z:mp> system injuries </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we found that expression of <z:chebi fb="125" ids="28260">Gal</z:chebi>-1 was remarkably up-regulated in activated astrocytes around ischemic <z:mpath ids='MPATH_124'>infarct</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, under ischemic conditions either in vitro or in vivo, <z:chebi fb="125" ids="28260">Gal</z:chebi>-1 was found to inhibit the proliferation of astrocytes in a dose-dependent manner, attenuate <z:mp ids='MP_0003354'>astrogliosis</z:mp> and down-regulate the <z:mp ids='MP_0003354'>astrogliosis</z:mp> associated expression of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase and interleukin-1Î² after the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these changes were blocked by <z:chebi fb="8" ids="17716">lactose</z:chebi>, suggesting a lectin dependent manner of <z:chebi fb="125" ids="28260">Gal</z:chebi>-1's function </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, 7-day <z:chebi fb="125" ids="28260">Gal</z:chebi>-1 treatment <z:mp ids='MP_0006043'>reduced apoptosis</z:mp> of neurons, decreased <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> volume and improved neurological function induced by the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Together, these findings indicate that through reducing <z:mp ids='MP_0003354'>astrogliosis</z:mp> related damages, <z:chebi fb="125" ids="28260">Gal</z:chebi>-1 is a potential therapeutical target for attenuating neuronal damage and promoting recovery of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
</text></document>